Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.  The report explores business and technological trends in the US coagulation testing market; provides leading supplier market shares estimates, as well as test volume forecasts for over 40 procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care center, surgery centers, nursing homes, and birth centers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. Strategic Recommendations - Product development and business expansion opportunities with significant market appeal. - “Ideal” product models with tentative prices and operating characteristics. - Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin... Research Beam Model: Research Beam Product ID: 322029 0 USD New
2015-2019 Coagulation Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015-2019 Coagulation Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

 
 
 

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500.


Summary


This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. 


The report explores business and technological trends in the US coagulation testing market; provides leading supplier market shares estimates, as well as test volume forecasts for over 40 procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care center, surgery centers, nursing homes, and birth centers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.


Strategic Recommendations


- Product development and business expansion

opportunities with significant market appeal.


- “Ideal” product models with tentative

prices and operating characteristics.


- Alternative market penetration

strategies for instrument and reagent suppliers.


- Potential market entry barriers and risks.


Coagulation Tests


Activated Clotting Time (ACT) (1), Activated Protein C Resistance,

Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,

D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,

Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,

Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,

Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,

Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,

Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,

Von Willebrand's Factor Fav/Ag, and others.


Sales and Market Share Analysis


- Sales and market shares of major

instrument and reagent suppliers.


Market Segmentation Analysis


- Comprehensive market

segmentation analysis, including:


Centralized Testing    

 

- Hospitals

- Commercial/Private Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices   

- Emergency Rooms       

- Operating/Recovery Suites     

- ICUs/CCUs

- Cancer Clinics       

- Ambulatory Care Centers       

- Surgery Centers

- Nursing Homes

- Birth Centers


- Test volume forecasts for over 40 major procedures

by market segment.


Current and Emerging Products


- Review of established and emerging procedures.


- Comparison of automated and semi-automated

analyzers from Diagnostica Stago, Helena, IL,

Siemens, Sysmex and other suppliers.


Technology Review


- Analysis of current and emerging technologies

and their potential market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Extensive strategic profiles of

major suppliers and emerging market entrants.


- The companies analyzed in the report include:


-  Abbott

-  ADI/American Diagnostica

-  Axis-Shield

-  Alere/Biosite/Inverness

-  Beckman Coulter/Danaher

-  Becton Dickinson

-  Bio/Data Corporation

-  Chrono-Log

-  Corgenix Medical

-  Diagnostica Stago/Trinity Biotech

-  Grifols

-  Helena Laboratories

-  Hyphen BioMed

-  Instrumentation Laboratory

-  ITC/Nexus Dx

-  Roche

-  Siemens

-  Sienco

-  Sysmex

-  Thermo Fisher

-  ZyCare/Alere

                                                                     

Contains 455 pages and 60 tables